// App-Quantinova.ai

P6-10-21 : Evaluation of genomic changes in ductal carcinoma in situ as potential biomarkers of recurrence risk

Researchers

Presenter

  • Dorothea Lesche

Principal Investigators

  • Hugo Saunders

  • Sakshi Mahale

  • Magnus Zenthoven

  • Siobhan Huges

  • Tanjina Kader

  • Niko Thio

  • Islam M Miligy

  • Jia-Min Pang

  • Andrew R Green

  • Emad A Rakha

  • Ian G Campbell

  • Stephen B Fox

  • Kylie Gorringe

Medical Centers

  • Division of Cancer Medicine, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia

  • Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia

  • Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Department of Histopathology, Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, United Kingdom

  • Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved